32 results on '"An, Jingjing"'
Search Results
2. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer
- Author
-
Jiajia Wang, Shudan Wang, Junli Wang, Jingjing Huang, Haishan Lu, Bin Pan, Hanyi Pan, Yanlun Song, Qianqian Deng, Xiaojun Jin, and Guiling Shi
- Subjects
cervical cancer ,cornichon homolog 4 ,immune landscape ,knockdown ,predictive model ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Cornichon homolog 4 (CNIH4) belongs to the CNIH family. It functions as an oncogene in many tumors. However, CNIH4's significance in the immune landscape and its predictive potential in cervical cancer (CESC) is unexplored. Methods CNIH4 levels and its effect on the survival of patients with CESC were evaluated using data retrieved from The Cancer Genome Atlas (TCGA). The oncogenic effect of CNIH4 in CESC was determined using small interfering RNA‐mediated transfected cell lines and tumorigenesis experiments in animal models. Results Higher expression of CNIH4 was found in advanced tumor and pathological stages, as well as lymph node metastasis. CNIH4 expression correlated positively with the infiltration of macrophages M2 and resting dendritic cells into the affected tissue. Additionally, functional enrichment of RNA‐sequencing of CNIH4‐knocked down CESC cell lines showed the association of CNIH4 to the PI3K‐Akt signaling pathway. Single‐sample gene set enrichment analysis highlighted several immune pathways that were elevated in the CESC samples with enhanced levels of CNIH4, including Type‐I and Type‐II IFN‐response pathways. The impact of CNIH4 on drug sensitivity was further assessed using the GDSC database. As CNIH4 is linked to the immune landscape in CESC, this study determined a four‐gene risk prediction signature utilizing CNIH4‐related immunomodulators. The risk score quantified from the prediction signature was an independent predictive indicator in CESC. Receiver operating characteristic curve analysis verified the good predictive ability of the four‐gene signature in TCGA‐CESC cohort. Thus, the CNIH4‐related model showed potential as an auxiliary TNM staging system tool. Conclusion CNIH4 may be an effective predictive biomarker for patients with cervical cancer, thus providing new ideas and research directions for CESC.
- Published
- 2023
- Full Text
- View/download PDF
3. Development of a nutritional screening and assessment indicator system for patients with esophageal cancer in China: Findings from the Delphi method
- Author
-
Jingjing Shang, Wen Dong, Peipei Huang, Yidan Sun, Yuxin He, Hui Li, Shengwu Liao, and Mei Li
- Subjects
Delphi method ,esophageal cancer ,index system ,nutritional assessment ,nutritional screening ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background In China, individuals diagnosed with esophageal cancer are confronted with an elevated risk of nutritional inadequacy or malnutrition throughout the course of their disease, a condition that contributes to various adverse clinical outcomes. A vast corpus of data are burgeoning at an unprecedented rate, primarily due to the revolutionary growth of digitalization technologies and artificial intelligence, notably within the domains of health care and medicine. The purpose of this investigation is to initiate the development of a nutritional screening and assessment indicator framework for patients with esophageal cancer within the Chinese context. We seek to furnish an instrumental reference to facilitate preparations for the forthcoming era of advanced, “deep,” evidence‐based medicine. Methods An integrative methodology was employed to forge the preliminary draft of the nutritional screening and assessment indicator system for preoperative patients with esophageal cancer. This encompassed a rigorous literature survey, in‐depth clinical practice investigation, and the facilitation of expert panel discussions. Thereafter, two iterative consultation phases were conducted using the Delphi method in China. The analytic hierarchy process was deployed to ascertain the weighting of each index within the definitive evaluation indicator system. Results The effective response rates for the dual rounds of expert consultation were 91.7% and 86.4%, with commensurate authority coefficients of 0.97 and 0.91. The Kendall harmony coefficients were ascertained to be 0.19 and 0.14 (p
- Published
- 2023
- Full Text
- View/download PDF
4. Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T‐cell lymphoma
- Author
-
Ziyuan Shen, Xicheng Chen, Cai Sun, Tianyi Lu, Yuye Shi, Hao Zhang, Jingjing Ye, Ling Wang, Taigang Zhu, Yuqing Miao, Xudong Zhang, Liang Wang, Guoqi Cai, and Wei Sang
- Subjects
clinicopathologic ,extranodal natural killer/T‐cell lymphoma ,nasal ,nonnasal ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background The clinicopathologic characteristics and prognosis of nasal and nonnasal extranodal natural killer T‐cell lymphoma (ENKTL) are considered to be different. However, the underlying features responsible for these differences are not well clarified especially in the era of asparaginase therapy. Methods In total, 1007 newly diagnosed ENKTL patients from 11 medical centers were included in this study. Clinicopathologic characteristics and survival data were collected. The chi‐squared test and Kruskal–Wallis test were utilized for the comparison of different groups. Univariable and multivariable Cox proportional hazards models were used to screen prognostic factors. Results Overall, 869 (86.3%) patients were nasal forms. Compared to patients with nasal ENKTL, nonnasal patients were at more advanced stages and had poor performance status, bone marrow involvement, elevated serum lactate dehydrogenase (LDH), and CD56‐negative status (p
- Published
- 2023
- Full Text
- View/download PDF
5. Elderly nasopharyngeal carcinoma patients (aged ≥70 years): Survival and treatment strategies
- Author
-
Gang Yang, Jingjing Huang, Ji Sun, and Li Wang
- Subjects
chemotherapy ,elderly ,IMRT ,nasopharyngeal carcinoma ,survival outcomes ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background With the coming of the aging society, the incidence of elderly nasopharyngeal carcinoma (NPC) has been increasing which may result in considerable disease burden; however, the optimal treatment strategy for elderly patients is still debatable. Methods and Results Clinical data on 294 elderly NPC patients aged ≥70 treated between 2009 and 2019 was analyzed. Kaplan–Meier method was used to estimate overall survival (OS) and cancer‐specific survival (CSS) rates. With a median follow‐up of 53.25 months, the 5‐year estimated OS and CSS for the entire group were 59.5% and 69.8%, respectively. 146 patients died within the follow‐up period, of which recurrence + metastasis (48%) and internal medical disease unrelated to NPC (32%) are the primary causes of death. On univariable analysis, (IMRT vs. 3D‐CRT) (p = 0.001; p = 0.000), T stage (p = 0.001; p = 0.000), N stage (p = 0.013; p = 0.000) and clinical stage (p = 0.000; p = 0.000) were associated with OS and CSS; Charlson Comorbidity Index (CCI) (p = 0.016) was associated with OS. The addition of chemotherapy (CT) correlated with better CSS (p = 0.039), but did not improve OS (p = 0.056) for stage III–IV subgroup. On multivariate analysis, advanced clinical stage independently predicted poorer OS (p = 0.002) and CSS (p = 0.000). In addition, the application of IMRT was an independent protective factor on both OS (p = 0.028) and CSS (p = 0.030). Conclusion IMRT is a reasonable treatment strategy to improve survival for elderly NPC patients aged over 70 years; consideration of adding chemotherapy for elderly population should be weighed carefully.
- Published
- 2023
- Full Text
- View/download PDF
6. Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
- Author
-
Yuyan Wu, Mingying Li, Guangqiang Meng, Yuechan Ma, Jingjing Ye, Tao Sun, and Chunyan Ji
- Subjects
acute myeloid leukemia ,immune checkpoint ,PD1 ,prognosis ,single nucleotide polymorphism ,susceptibility ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Chemotherapy is still the standard regimen for treating acute myeloid leukemia (AML) and its disappointing efficacy requires the urgent need for new therapeutic targets. It is well known that immune response plays an increasingly significant role in the pathogenesis of AML. Methods We detected nine single nucleotide polymorphisms (SNPs) in immune checkpoint‐related genes, including PD1, LAG3, TIM3, and TIGIT in 285 AML inpatients and 324 healthy controls. SNP genotyping was performed on the MassARRAY platform. Furthermore, we analyzed the relationship between the susceptibility and prognosis of AML and the selected SNPs. Results Our results showed that rs2227982 and rs10204525 in PD1 were significantly associated with susceptibility to AML after false discovery rate correction. PD1 rs10204525 also showed a significant correlation with the response to chemotherapy and risk stratification of AML. Importantly, the AA genotype of PD1 (rs2227982) under the recessive model showed a negative impact on AML prognosis independently. Conclusions Our results indicate that PD1 SNPs are important for susceptibility and prognosis in AML, which may provide a new therapeutic target for AML patients.
- Published
- 2023
- Full Text
- View/download PDF
7. Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B‐cell lymphoma
- Author
-
Xiaoya Yun, Jiefei Bai, Ru Feng, Jiangtao Li, Ting Wang, Yazi Yang, Jingjing Yin, Long Qian, Shuai Zhang, Qingyun Cao, Xiaoxuan Xue, Hongmei Jing, and Hui Liu
- Subjects
diffuse large B‐cell lymphoma ,early mortality ,geriatric assessment ,prognosis ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Geriatric assessment can aid in optimizing treatment strategies and supportive interventions for older patients with diffuse large B‐cell lymphoma (DLBCL). Fondazione Italiana Linformi has recently introduced novel geriatric assessment tools, simplified Geriatric Assessment (sGA) and Elderly Prognostic Index (EPI), aimed at tailoring the treatment and predicting the outcomes for older patients with DLBCL. The objectives of this study are the validation and possible modification of the sGA and EPI in China. In the study, both sGA and EPI demonstrated the predictive capabilities for overall survival (OS) and early mortality (both p
- Published
- 2024
- Full Text
- View/download PDF
8. Health insurance as a moderator in the relationship between financial toxicity and medical cost‐coping behaviors: Evidence from patients with lung cancer in China
- Author
-
Yongchun Cui, Jingjing Lv, Xiaoyu Hu, and Dawei Zhu
- Subjects
China ,financial toxicity ,health insurance ,medical cost‐coping behaviors ,patients with lung cancer ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Objective This study investigates the relationship between financial toxicity and medical cost‐coping behaviors (MCCB) in Chinese patients with lung cancer, with a particular focus on the moderating role of health insurance. Methods We surveyed 218 patients with lung cancer and assessed their Comprehensive Score for Financial Toxicity (COST) and self‐reported MCCB. Patients were categorized into Urban Employee's Basic Medical Insurance (UEBMI) group and Urban–Rural Resident Basic Medical Insurance Scheme (URRBMI) groups by their medical insurance, and matched for socioeconomic, demographic, and disease characteristics via propensity score. Results Significant different characteristics were noted between UEBMI patients and URRBMI patients. Patients with UEBMI had higher COST scores but lower levels of MCCB compared to URRBMI patients in the original dataset. After data matching, multivariate logit regression analysis showed that better financial toxicity was associated with lower levels of MCCB (OR = 0.95, 95% CI: 0.92–0.99). Health insurance type did not have a direct association with cost‐coping behaviors, but an interaction was observed between health insurance type and financial toxicity. Among patients with URRBMI, better financial toxicity was associated with lower levels of cost‐coping behaviors (OR = 0.89, 95% CI: 0.83–0.95). Patients with UEBMI had a lower probability of engaging in any cost‐coping behaviors in situations of worse financial toxicity compared to patients with URRBMI. Conclusion The findings suggest that financial toxicity is correlated with MCCB in Chinese patients with lung cancer. The type of health insurance, specifically UEBMI and URRBMI, plays a moderating role in this relationship. Understanding these dynamics is essential for developing targeted interventions and policies to mitigate financial toxicity and improve patients' management of medical costs.
- Published
- 2024
- Full Text
- View/download PDF
9. Establishment and validation of a prognostic nomogram for postoperative patients with gastric cardia adenocarcinoma: A study based on the Surveillance, Epidemiology, and End Results database and a Chinese cohort
- Author
-
Lei Wang, Jingjing Ge, Liwen Feng, Zehua Wang, Wenjia Wang, Huiqiong Han, and Yanru Qin
- Subjects
gastric cardia adenocarcinoma ,LODDS ,nomogram ,prognosis ,SEER database ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Gastric cardia adenocarcinoma (GCA) is a highly fatal form of cancer in humans. The aim of this study was to extract clinicopathological data of postoperative patients with GCA from the Surveillance, Epidemiology, and End Results database, analyze prognostic risk factors, and build a nomogram. Methods In this study, the clinical information of 1448 patients with GCA who underwent radical surgery and were diagnosed between 2010 and 2015 was extracted from the SEER database. The patients were then randomly divided into training (n = 1013) and internal validation (n = 435) cohorts at a 7:3 ratio. The study also included an external validation cohort (n = 218) from a Chinese hospital. The study used the Cox and LASSO models to pinpoint the independent risk factors linked to GCA. The prognostic model was constructed according to the results of the multivariate regression analysis. To assess the predictive accuracy of the nomogram, four methods were used: C‐index, calibration curve, time‐dependent ROC curve, and DCA curve. Kaplan–Meier survival curves were also generated to illustrate the differences in cancer‐specific survival (CSS) between the groups. Results The results of the multivariate Cox regression analysis showed that age, grade, race, marital status, T stage, and log odds of positive lymph nodes (LODDS) were independently associated with cancer‐specific survival in the training cohort. Both the C‐index and AUC values depicted in the nomogram were greater than 0.71. The calibration curve revealed that the nomogram's CSS prediction was consistent with the actual outcomes. The decision curve analysis suggested moderately positive net benefits. Based on the nomogram risk score, significant differences in survival between the high‐ and low‐risk groups were observed. Conclusions Race, age, marital status, differentiation grade, T stage, and LODDS are independent predictors of CSS in patients with GCA after radical surgery. Our predictive nomogram constructed based on these variables demonstrated good predictive ability.
- Published
- 2023
- Full Text
- View/download PDF
10. It is not the time to abandon intraoperative frozen section in endometrioid adenocarcinoma: A large‐scale, multi‐center, and retrospective study
- Author
-
Xiaohang Yang, Jingjing Yin, Yu Fu, Yuanming Shen, Chuyao Zhang, Shuzhong Yao, Congjian Xu, Min Xia, Ge Lou, Jihong Liu, Bei Lin, Jianliu Wang, Weidong Zhao, Jieqing Zhang, Wenjun Cheng, Hongyan Guo, Ruixia Guo, Fengxia Xue, Xipeng Wang, Lili Han, Xiaomao Li, Ping Zhang, Jianguo Zhao, Wenting Li, Yingyu Dou, Zizhuo Wang, Jingbo Liu, Kezhen Li, Gang Chen, Chaoyang Sun, Beibei Wang, and Xingsheng Yang
- Subjects
endometrioid adenocarcinoma ,high‐grade ,intraoperative frozen section ,myometrial invasion ,retrospective studies ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Introduction Stage IB (deep myometrial invasion) high‐grade endometrioid adenocarcinoma (EA), regardless of LVSI status, is classified into high‐intermediate risk groups, requiring surgical lymph node staging. Intraoperative frozen section (IFS) is commonly used, but its adequacy and reliability vary between reports. Hence, we determined the utility of IFS in identification of high‐risk factors, including deep myometrial invasion and high‐grade. Method We retrospectively analyzed 9,985 cases operated with hysterectomy and diagnosed with FIGO stage I/II EA in postoperative paraffin section (PS) results at 30 Chinese hospitals from 2000 to 2019. We determined diagnostic performance of IFS and investigated whether the addition of IFS to preoperative biopsy and imaging could improve identification of high‐risk factors. Results IFS and postoperative PS presented the highest concordance in assessing deep myometrial invasion (Kappa: 0.834), followed by intraoperative gross examination (IGE Kappa: 0.643), MRI (Kappa: 0.395), and CT (Kappa: 0.207). IFS and postoperative PS presented the highest concordance for high‐grade EA (Kappa: 0.585) compared to diagnostic curettage (D&C 0.226) and hysteroscope (Hys 0.180). Sensitivity and specificity for detecting deep myometrial invasion were 86.21 and 97.20% for IFS versus 51.72 and 88.81% for MRI, 68.97 and 94.41% for IGE. These figures for detecting high‐grade EA were 58.21 and 96.50% for IFS versus 16.42 and 98.83% for D&C, 13.43 and 98.64% for Hys. Parallel strategies, including MRI‐IFS (Kappa: 0.626), D&C‐IFS (Kappa: 0.595), and Hys‐IFS (Kappa: 0.578) improved the diagnostic efficiencies of individual preoperative examinations. Based on the high sensitivity of IFS, parallel strategies improved the sensitivities of preoperative examinations to 89.66% (MRI), 64.18% (D&C), 62.69% (Hys), respectively, and these differences were statistically significant (p = 0.000). Conclusion IFS presented reasonable agreement rates predicting postoperative PS results, including deep myometrial invasion and high‐grade. IFS helps identify high‐intermediate risk patients in preoperative biopsy and MRI and guides intraoperative lymphadenectomy decisions in EA.
- Published
- 2023
- Full Text
- View/download PDF
11. ABO blood groups and expression of blood group antigens of epithelial ovarian cancer in Chinese women
- Author
-
Chao Wang, Jingjing Zhou, Lili Wang, Tongyu Xing, Hongji Dai, Yao Zhou, Lisha Qi, Yanrui Zhao, Caiyun Huang, Ding Li, Haixin Li, Mulin Jun Li, Ben Liu, Hong Zheng, Kexin Chen, and Lian Li
- Subjects
ABH antigens ,ABO blood group ,epithelial ovarian cancer ,risk ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background ABO blood groups has been associated with risk of several cancers; however, the results for an association with ovarian cancer are inconsistent and little is known about the expression of histo‐blood group (ABH) antigens and ABO gene in ovarian tumor tissues. Methods To assess the impact of genotype‐derived ABO blood types on the risk of EOC, we conducted a case–control study in 1,870 EOC and 4,829 controls. Expression of A and B antigen in 70 pairs of ovarian tumor tissues and adjacent normal tissues were detected by immunohistochemistry. Gene expression and DNA methylation profiling was conducted in ovarian tumor tissues. Results We identified that blood group A was associated with increased risk for EOC compared to blood group O (OR = 1.18, 95% CI = 1.03–1.36, p = 0.019). Increased frequency of aberrant expression of histo‐blood group antigens was observed in patients with blood group A (76.5%) compared to patients with blood group O (21.1%) and B (5.0%) by immunohistochemistry (p
- Published
- 2023
- Full Text
- View/download PDF
12. Favorable outcome of neoadjuvant endocrine treatment than surgery‐first in female HR‐positive/HER2‐negative breast cancer patients—A NCDB analysis (2010–2016)
- Author
-
Xu, Peng, primary, Luo, Wen, additional, Hu, Jingjing, additional, Ma, Xiaobin, additional, Hao, Qian, additional, Hui, Wentao, additional, Zhou, Zhangjian, additional, Lin, Shuai, additional, Wang, Meng, additional, Wu, Hao, additional, Dai, Zhijun, additional, and Kang, Huafeng, additional
- Published
- 2024
- Full Text
- View/download PDF
13. The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer
- Author
-
Hanxiao Chen, Dingzhi Huang, Gen Lin, Xue Yang, Minglei Zhuo, Yujia Chi, Xiaoyu Zhai, Bo Jia, Jingjing Wang, Yuyan Wang, Jianjie Li, Tongtong An, Meina Wu, Ziping Wang, and Jun Zhao
- Subjects
efficacy ,KRAS mutation ,NSCLC ,prevalence ,treatme ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Objective Kirsten rat sarcoma viral oncogene homolog (KRAS) is an important driver gene of non‐small cell lung cancer (NSCLC). Despite a rapid progress achieved in the targeted therapy, chemotherapy remains the standard treatment option for patients with KRAS‐mutant NSCLC. This study aimed to assess real‐world data of Chinese patients with KRAS‐mutant NSCLC undergoing chemotherapy and/or immunotherapy. Methods KRAS mutational status was analyzed using next‐generation sequencing of 150,327 NSCLC patients from the Lung Cancer Big Data Precise Treatment Collaboration Group (LANDSCAPE) project (Cohort I). Treatment data were collected and analyzed retrospectively from 4348 NSCLC patients who were admitted to the Peking University Cancer Hospital and Institute between January 2009 and October 2020 (Cohort II). Results In Cohort I, 18,224 patients were detected with KRAS mutations (12.1%) of whom G12C (29.6%) was the most frequent subtype, followed by G12D (18.1%) and G12V (17.5%). In case of concomitant mutations, TP53 had the highest incidence of 33.6%, followed by EGFR (11.6%), STK11 (10.4%), KEAP1(6.2%), and CDKN2A (6.0%). Cohort II included 497 patients (11.4%) with KRAS mutations. In the first‐line chemotherapeutic analysis of Cohort II, patients benefited more from the pemetrexed/platinum (PP) regimen than the gemcitabine/platinum (GP) or taxanes/platinum (TP) regimen (median progression‐free survival [PFS], 6.4 vs. 4.9 vs. 5.6 months, hazard ratio [HR] = 0.65, 95% confidence interval [CI] 0.48–0.88, p = 0.033 and HR = 0.69, 95% CI 0.47–1.00, p = 0.05, respectively), with no significant difference when combined with bevacizumab. Regarding patients who received immune checkpoint inhibitors (ICIs), the objective response rate was 26% for a median PFS of 9.6 months (95% CI 6.16–13.03). Patients who received ICIs combined with chemotherapy had a significantly longer survival than monotherapy (median PFS, 13.9 vs. 5.2 months, HR = 0.59, 95% CI 0.35–0.99, p = 0.049). Conclusion KRAS is an important driver gene in NSCLC, compromising 12.1% in this study, and G12C was noted as the most common subtype. Patients with KRAS‐mutant NSCLC could benefit from pemetrexed‐based chemotherapy and ICIs.
- Published
- 2022
- Full Text
- View/download PDF
14. Identification of a novel six‐gene signature with potential prognostic and therapeutic value in cervical cancer
- Author
-
Xinyu Qu, Zhiwen Shi, Jingjing Guo, Chenyan Guo, Junjun Qiu, and Keqin Hua
- Subjects
cervical cancer ,gene signature ,prognosis ,tumour immune microenvironment ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Introduction Cervical cancer has high mortality, high recurrence and poor prognosis. Although prognostic biomarkers such as clinicopathological features have been proposed, their accuracy and precision are far from satisfactory. Therefore, novel biomarkers are urgently needed for disease surveillance, prognosis prediction and treatment selection. Materials Differentially expressed genes (DEGs) between cervical cancer and normal tissues from three microarray datasets extracted from the Gene Expression Omnibus platform were identified and screened. Based on these DEGs, a six‐gene prognostic signature was constructed using cervical squamous cell carcinoma and endocervical adenocarcinoma data from The Cancer Genome Atlas. Next, the molecular functions and related pathways of the six genes were investigated through gene set enrichment analysis and co‐expression analysis. Additionally, immunophenoscore analysis and the QuartataWeb Server were employed to explore the therapeutic value of the six‐gene signature. Results We discovered 178 overlapping DEGs in three microarray datasets and established a six‐gene (APOC1, GLTP, ISG20, SPP1, SLC24A3 and UPP1) prognostic signature with stable and excellent performance in predicting overall survival in different subgroups. Intriguingly, the six‐gene signature was closely associated with the immune response and tumour immune microenvironment. The six‐gene signature might be used for predicting response to immune checkpoint inhibitors (ICIs) and the six genes may serve as new drug targets for cervical cancer. Conclusion Our study established a novel six‐gene (APOC1, GLTP, ISG20, SPP1, SLC24A3 and UPP1) signature that was closely associated with the immune response and tumour immune microenvironment. The six‐gene signature was indicative of aggressive features of cervical cancer and therefore might serve as a promising biomarker for predicting not only overall survival but also ICI treatment effectiveness. Moreover, three genes (UPP1, ISG20 and GLTP) within the six‐gene signature have the potential to become novel drug targets.
- Published
- 2021
- Full Text
- View/download PDF
15. ALOX5‐5‐HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation
- Author
-
Jianjun Tang, Chuang Zhang, Jingjing Lin, Peng Duan, Jian Long, and Hongyan Zhu
- Subjects
5‐HETE ,Alox5 ,chemotherapy ,gastric cancer ,MEK/ERK ,zileuton ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Recent studies highlight the regulatory role of arachidonate lipoxygenase5 (Alox5) and its metabolite 5‐hydroxyeicosatetraenoic acid (5‐HETE) in cancer tumorigenesis and progression. In this study, we analyzed the expression, biological function and the downstream signaling of Alox5 in gastric cancer. Methods Alox5 protein levels were measured using IHC and ELISA. Growth, migration and survival assays were performed. Phosphorylation of molecules involved in growth and survival signaling were analyzed by WB. Analysis of variance and t‐test were used for statistic analysis. Results Alox5 and 5‐HETE levels were upregulated in gastric cancer patients. ALOX5 overexpression or 5‐HETE addition activates gastric cancer cells and reduces chemotherapy’s efficacy. In contrast, ALOX5 inhibition via genetic and pharmacological approaches suppresses gastric cancer cells and enhances chemotherapy’s efficacy. In addition, Alox5 inhibition led to suppression of ERK‐mediated signaling pathways whereas ALOX5‐5‐HETE activates ERK‐mediated signaling in gastric cancer cells. Conclusions Our work demonstrates the critical role of ALOX5‐5‐HETE in gastric cancer and provides pre‐clinical evidence to initialize clinical trial using zileuton in combination with chemotherapy for treating gastric cancer.
- Published
- 2021
- Full Text
- View/download PDF
16. Health insurance as a moderator in the relationship between financial toxicity and medical cost‐coping behaviors: Evidence from patients with lung cancer in China
- Author
-
Cui, Yongchun, primary, Lv, Jingjing, additional, Hu, Xiaoyu, additional, and Zhu, Dawei, additional
- Published
- 2024
- Full Text
- View/download PDF
17. Validation and modification of simplified Geriatric Assessment and Elderly Prognostic Index: Effective tools for older patients with diffuse large B‐cell lymphoma
- Author
-
Yun, Xiaoya, primary, Bai, Jiefei, additional, Feng, Ru, additional, Li, Jiangtao, additional, Wang, Ting, additional, Yang, Yazi, additional, Yin, Jingjing, additional, Qian, Long, additional, Zhang, Shuai, additional, Cao, Qingyun, additional, Xue, Xiaoxuan, additional, Jing, Hongmei, additional, and Liu, Hui, additional
- Published
- 2023
- Full Text
- View/download PDF
18. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer
- Author
-
Wang, Jiajia, primary, Wang, Shudan, additional, Wang, Junli, additional, Huang, Jingjing, additional, Lu, Haishan, additional, Pan, Bin, additional, Pan, Hanyi, additional, Song, Yanlun, additional, Deng, Qianqian, additional, Jin, Xiaojun, additional, and Shi, Guiling, additional
- Published
- 2023
- Full Text
- View/download PDF
19. Development of a nutritional screening and assessment indicator system for patients with esophageal cancer in China: Findings from the Delphi method
- Author
-
Shang, Jingjing, primary, Dong, Wen, additional, Huang, Peipei, additional, Sun, Yidan, additional, He, Yuxin, additional, Li, Hui, additional, Liao, Shengwu, additional, and Li, Mei, additional
- Published
- 2023
- Full Text
- View/download PDF
20. Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T‐cell lymphoma
- Author
-
Shen, Ziyuan, primary, Chen, Xicheng, additional, Sun, Cai, additional, Lu, Tianyi, additional, Shi, Yuye, additional, Zhang, Hao, additional, Ye, Jingjing, additional, Wang, Ling, additional, Zhu, Taigang, additional, Miao, Yuqing, additional, Zhang, Xudong, additional, Wang, Liang, additional, Cai, Guoqi, additional, and Sang, Wei, additional
- Published
- 2023
- Full Text
- View/download PDF
21. Elderly nasopharyngeal carcinoma patients (aged ≥70 years): Survival and treatment strategies
- Author
-
Yang, Gang, primary, Huang, Jingjing, additional, Sun, Ji, additional, and Wang, Li, additional
- Published
- 2023
- Full Text
- View/download PDF
22. Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
- Author
-
Wu, Yuyan, primary, Li, Mingying, additional, Meng, Guangqiang, additional, Ma, Yuechan, additional, Ye, Jingjing, additional, Sun, Tao, additional, and Ji, Chunyan, additional
- Published
- 2023
- Full Text
- View/download PDF
23. Establishment and validation of a prognostic nomogram for postoperative patients with gastric cardia adenocarcinoma: A study based on the Surveillance, Epidemiology, and End Results database and a Chinese cohort
- Author
-
Wang, Lei, primary, Ge, Jingjing, additional, Feng, Liwen, additional, Wang, Zehua, additional, Wang, Wenjia, additional, Han, Huiqiong, additional, and Qin, Yanru, additional
- Published
- 2023
- Full Text
- View/download PDF
24. <scp>ABO</scp> blood groups and expression of blood group antigens of epithelial ovarian cancer in Chinese women
- Author
-
Chao Wang, Jingjing Zhou, Lili Wang, Tongyu Xing, Hongji Dai, Yao Zhou, Lisha Qi, Yanrui Zhao, Caiyun Huang, Ding Li, Haixin Li, Mulin Jun Li, Ben Liu, Hong Zheng, Kexin Chen, and Lian Li
- Subjects
Cancer Research ,Oncology ,Radiology, Nuclear Medicine and imaging - Abstract
ABO blood groups has been associated with risk of several cancers; however, the results for an association with ovarian cancer are inconsistent and little is known about the expression of histo-blood group (ABH) antigens and ABO gene in ovarian tumor tissues.To assess the impact of genotype-derived ABO blood types on the risk of EOC, we conducted a case-control study in 1,870 EOC and 4,829 controls. Expression of A and B antigen in 70 pairs of ovarian tumor tissues and adjacent normal tissues were detected by immunohistochemistry. Gene expression and DNA methylation profiling was conducted in ovarian tumor tissues.We identified that blood group A was associated with increased risk for EOC compared to blood group O (OR = 1.18, 95% CI = 1.03-1.36, p = 0.019). Increased frequency of aberrant expression of histo-blood group antigens was observed in patients with blood group A (76.5%) compared to patients with blood group O (21.1%) and B (5.0%) by immunohistochemistry (p 0.001). ABO gene expression was down-regulated in ovarian tumor tissues compared with paired adjacent normal tissues (p = 0.027). In addition, ABO gene expression was positively correlated with NFYB (r = 0.38, p 0.001) and inversely correlated with DNA methylation level of four CpG sites on ABO gene (cg11879188, r = - 0.3, p = 0.002; cg22535403, r = - 0.30, p = 0.002; cg13506600, r = - 0.22, p = 0.025; cg07241568, r = - 0.21, p = 0.049) in ovarian tumor tissues.We identified blood group A was associated with increased EOC risk in Chinese women and provided the clues of the possible molecular mechanisms of blood group A related to ovarian cancer risk.
- Published
- 2022
25. It is not the time to abandon intraoperative frozen section in endometrioid adenocarcinoma: A large‐scale, multi‐center, and retrospective study
- Author
-
Yang, Xiaohang, primary, Yin, Jingjing, additional, Fu, Yu, additional, Shen, Yuanming, additional, Zhang, Chuyao, additional, Yao, Shuzhong, additional, Xu, Congjian, additional, Xia, Min, additional, Lou, Ge, additional, Liu, Jihong, additional, Lin, Bei, additional, Wang, Jianliu, additional, Zhao, Weidong, additional, Zhang, Jieqing, additional, Cheng, Wenjun, additional, Guo, Hongyan, additional, Guo, Ruixia, additional, Xue, Fengxia, additional, Wang, Xipeng, additional, Han, Lili, additional, Li, Xiaomao, additional, Zhang, Ping, additional, Zhao, Jianguo, additional, Li, Wenting, additional, Dou, Yingyu, additional, Wang, Zizhuo, additional, Liu, Jingbo, additional, Li, Kezhen, additional, Chen, Gang, additional, Sun, Chaoyang, additional, Wang, Beibei, additional, and Yang, Xingsheng, additional
- Published
- 2023
- Full Text
- View/download PDF
26. ABO blood groups and expression of blood group antigens of epithelial ovarian cancer in Chinese women
- Author
-
Wang, Chao, primary, Zhou, Jingjing, additional, Wang, Lili, additional, Xing, Tongyu, additional, Dai, Hongji, additional, Zhou, Yao, additional, Qi, Lisha, additional, Zhao, Yanrui, additional, Huang, Caiyun, additional, Li, Ding, additional, Li, Haixin, additional, Li, Mulin Jun, additional, Liu, Ben, additional, Zheng, Hong, additional, Chen, Kexin, additional, and Li, Lian, additional
- Published
- 2022
- Full Text
- View/download PDF
27. Identification of a novel six‐gene signature with potential prognostic and therapeutic value in cervical cancer
- Author
-
Junjun Qiu, Xinyu Qu, Chenyan Guo, Jingjing Guo, Zhiwen Shi, and Keqin Hua
- Subjects
Cancer Research ,Microarray ,Bioinformatics ,cervical cancer ,Immune checkpoint inhibitors ,Uterine Cervical Neoplasms ,Biology ,gene signature ,Immune system ,Tumor Microenvironment ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Gene ,Research Articles ,RC254-282 ,Cervical cancer ,tumour immune microenvironment ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Middle Aged ,Gene signature ,medicine.disease ,Gene Expression Regulation, Neoplastic ,Oncology ,Cancer research ,Biomarker (medicine) ,Female ,Identification (biology) ,prognosis ,Research Article - Abstract
Introduction Cervical cancer has high mortality, high recurrence and poor prognosis. Although prognostic biomarkers such as clinicopathological features have been proposed, their accuracy and precision are far from satisfactory. Therefore, novel biomarkers are urgently needed for disease surveillance, prognosis prediction and treatment selection. Materials Differentially expressed genes (DEGs) between cervical cancer and normal tissues from three microarray datasets extracted from the Gene Expression Omnibus platform were identified and screened. Based on these DEGs, a six‐gene prognostic signature was constructed using cervical squamous cell carcinoma and endocervical adenocarcinoma data from The Cancer Genome Atlas. Next, the molecular functions and related pathways of the six genes were investigated through gene set enrichment analysis and co‐expression analysis. Additionally, immunophenoscore analysis and the QuartataWeb Server were employed to explore the therapeutic value of the six‐gene signature. Results We discovered 178 overlapping DEGs in three microarray datasets and established a six‐gene (APOC1, GLTP, ISG20, SPP1, SLC24A3 and UPP1) prognostic signature with stable and excellent performance in predicting overall survival in different subgroups. Intriguingly, the six‐gene signature was closely associated with the immune response and tumour immune microenvironment. The six‐gene signature might be used for predicting response to immune checkpoint inhibitors (ICIs) and the six genes may serve as new drug targets for cervical cancer. Conclusion Our study established a novel six‐gene (APOC1, GLTP, ISG20, SPP1, SLC24A3 and UPP1) signature that was closely associated with the immune response and tumour immune microenvironment. The six‐gene signature was indicative of aggressive features of cervical cancer and therefore might serve as a promising biomarker for predicting not only overall survival but also ICI treatment effectiveness. Moreover, three genes (UPP1, ISG20 and GLTP) within the six‐gene signature have the potential to become novel drug targets., Our study established a novel six‐gene (APOC1, GLTP, ISG20, SPP1, SLC24A3 and UPP1) signature that was closely associated with the immune response and the tumour immune microenvironment. The six‐gene signature was indicative of aggressive features of cervical cancer and therefore might serve as a promising biomarker for predicting not only overall survival but also immune checkpoint inhibitor treatment effectiveness. Moreover, three genes (UPP1, ISG20 and GLTP) within the six‐gene signature have the potential to become novel drug targets.
- Published
- 2021
28. ALOX5‐5‐HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation
- Author
-
Hongyan Zhu, Peng Duan, Chuang Zhang, Jian Long, Jingjing Lin, and Jianjun Tang
- Subjects
0301 basic medicine ,MAPK/ERK pathway ,Cancer Research ,Cell Survival ,MAP Kinase Signaling System ,medicine.medical_treatment ,Antineoplastic Agents ,5‐HETE ,medicine.disease_cause ,chemotherapy ,03 medical and health sciences ,0302 clinical medicine ,Stomach Neoplasms ,Hydroxyeicosatetraenoic Acids ,Medicine ,Humans ,Hydroxyurea ,Radiology, Nuclear Medicine and imaging ,Lipoxygenase Inhibitors ,Phosphorylation ,Research Articles ,RC254-282 ,Cancer Biology ,Cell Proliferation ,Chemotherapy ,Analysis of Variance ,Arachidonate 5-Lipoxygenase ,business.industry ,gastric cancer ,Cancer ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Zileuton ,medicine.disease ,Alox5 ,Up-Regulation ,zileuton ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer cell ,Cancer research ,Disease Progression ,Signal transduction ,business ,Carcinogenesis ,MEK/ERK ,medicine.drug ,Research Article - Abstract
Background Recent studies highlight the regulatory role of arachidonate lipoxygenase5 (Alox5) and its metabolite 5‐hydroxyeicosatetraenoic acid (5‐HETE) in cancer tumorigenesis and progression. In this study, we analyzed the expression, biological function and the downstream signaling of Alox5 in gastric cancer. Methods Alox5 protein levels were measured using IHC and ELISA. Growth, migration and survival assays were performed. Phosphorylation of molecules involved in growth and survival signaling were analyzed by WB. Analysis of variance and t‐test were used for statistic analysis. Results Alox5 and 5‐HETE levels were upregulated in gastric cancer patients. ALOX5 overexpression or 5‐HETE addition activates gastric cancer cells and reduces chemotherapy’s efficacy. In contrast, ALOX5 inhibition via genetic and pharmacological approaches suppresses gastric cancer cells and enhances chemotherapy’s efficacy. In addition, Alox5 inhibition led to suppression of ERK‐mediated signaling pathways whereas ALOX5‐5‐HETE activates ERK‐mediated signaling in gastric cancer cells. Conclusions Our work demonstrates the critical role of ALOX5‐5‐HETE in gastric cancer and provides pre‐clinical evidence to initialize clinical trial using zileuton in combination with chemotherapy for treating gastric cancer., Our work demonstrates that the ALOX5‐5‐HETE axis promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation and provides pre‐clinical evidence to initialize clinical trials using zileuton in combination with chemotherapy for the treatment of gastric cancer.
- Published
- 2021
29. ABO blood groups and expression of blood group antigens of epithelial ovarian cancer in Chinese women.
- Author
-
Wang, Chao, Zhou, Jingjing, Wang, Lili, Xing, Tongyu, Dai, Hongji, Zhou, Yao, Qi, Lisha, Zhao, Yanrui, Huang, Caiyun, Li, Ding, Li, Haixin, Li, Mulin Jun, Liu, Ben, Zheng, Hong, Chen, Kexin, and Li, Lian
- Subjects
- *
BLOOD group antigens , *ABO blood group system , *BLOOD grouping & crossmatching , *CHINESE people , *BLOOD groups , *OVARIAN epithelial cancer , *OVARIAN cancer - Abstract
Background: ABO blood groups has been associated with risk of several cancers; however, the results for an association with ovarian cancer are inconsistent and little is known about the expression of histo‐blood group (ABH) antigens and ABO gene in ovarian tumor tissues. Methods: To assess the impact of genotype‐derived ABO blood types on the risk of EOC, we conducted a case–control study in 1,870 EOC and 4,829 controls. Expression of A and B antigen in 70 pairs of ovarian tumor tissues and adjacent normal tissues were detected by immunohistochemistry. Gene expression and DNA methylation profiling was conducted in ovarian tumor tissues. Results: We identified that blood group A was associated with increased risk for EOC compared to blood group O (OR = 1.18, 95% CI = 1.03–1.36, p = 0.019). Increased frequency of aberrant expression of histo‐blood group antigens was observed in patients with blood group A (76.5%) compared to patients with blood group O (21.1%) and B (5.0%) by immunohistochemistry (p < 0.001). ABO gene expression was down‐regulated in ovarian tumor tissues compared with paired adjacent normal tissues (p = 0.027). In addition, ABO gene expression was positively correlated with NFYB (r = 0.38, p < 0.001) and inversely correlated with DNA methylation level of four CpG sites on ABO gene (cg11879188, r = − 0.3, p = 0.002; cg22535403, r = − 0.30, p = 0.002; cg13506600, r = − 0.22, p = 0.025; cg07241568, r = − 0.21, p = 0.049) in ovarian tumor tissues. Conclusion: We identified blood group A was associated with increased EOC risk in Chinese women and provided the clues of the possible molecular mechanisms of blood group A related to ovarian cancer risk. We identified blood group A was associated with increased EOC risk in Chinese women. We provided the clues of the possible molecular mechanisms of blood group A related to ovarian cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. The prevalence and real‐world therapeutic analysis of Chinese patients with KRAS‐Mutant Non‐Small Cell lung cancer
- Author
-
Chen, Hanxiao, primary, Huang, Dingzhi, additional, Lin, Gen, additional, Yang, Xue, additional, Zhuo, Minglei, additional, Chi, Yujia, additional, Zhai, Xiaoyu, additional, Jia, Bo, additional, Wang, Jingjing, additional, Wang, Yuyan, additional, Li, Jianjie, additional, An, Tongtong, additional, Wu, Meina, additional, Wang, Ziping, additional, and Zhao, Jun, additional
- Published
- 2022
- Full Text
- View/download PDF
31. Identification of a novel six‐gene signature with potential prognostic and therapeutic value in cervical cancer
- Author
-
Qu, Xinyu, primary, Shi, Zhiwen, additional, Guo, Jingjing, additional, Guo, Chenyan, additional, Qiu, Junjun, additional, and Hua, Keqin, additional
- Published
- 2021
- Full Text
- View/download PDF
32. ALOX5‐5‐HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation.
- Author
-
Tang, Jianjun, Zhang, Chuang, Lin, Jingjing, Duan, Peng, Long, Jian, and Zhu, Hongyan
- Subjects
STOMACH cancer ,TUMOR growth ,SURVIVAL analysis (Biometry) ,CANCER invasiveness ,COMBINATION drug therapy - Abstract
Background: Recent studies highlight the regulatory role of arachidonate lipoxygenase5 (Alox5) and its metabolite 5‐hydroxyeicosatetraenoic acid (5‐HETE) in cancer tumorigenesis and progression. In this study, we analyzed the expression, biological function and the downstream signaling of Alox5 in gastric cancer. Methods: Alox5 protein levels were measured using IHC and ELISA. Growth, migration and survival assays were performed. Phosphorylation of molecules involved in growth and survival signaling were analyzed by WB. Analysis of variance and t‐test were used for statistic analysis. Results: Alox5 and 5‐HETE levels were upregulated in gastric cancer patients. ALOX5 overexpression or 5‐HETE addition activates gastric cancer cells and reduces chemotherapy's efficacy. In contrast, ALOX5 inhibition via genetic and pharmacological approaches suppresses gastric cancer cells and enhances chemotherapy's efficacy. In addition, Alox5 inhibition led to suppression of ERK‐mediated signaling pathways whereas ALOX5‐5‐HETE activates ERK‐mediated signaling in gastric cancer cells. Conclusions: Our work demonstrates the critical role of ALOX5‐5‐HETE in gastric cancer and provides pre‐clinical evidence to initialize clinical trial using zileuton in combination with chemotherapy for treating gastric cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.